Relationship between metabolic syndrome and its components with bone densitometry in postmenopausal women

Abbasi, Moslem; Farzam, Seyed Amir; Mamaghani, Zahra; Yazdi, Z Rezaei

doi:10.1016/j.dsx.2016.12.008

Cited by 19 publications

(16 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It is also highly associated with obesity, a strong protective factor against osteoporosis due to the increased mechanical load on bones [ 14 ]. However, studies have provided inconsistent results on the association between MS and osteoporosis [ 15 – 19 ]. A negative association between MS and osteoporosis, or low bone mass density, was shown to be reversed after BMI adjustment [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants

2018

View full text Add to dashboard Cite

SummaryThis study examined the association between metabolic syndrome and osteoporosis among middle-aged and elderly Taiwanese participants. After controlling for body mass index, age, liver and renal functions, and nutrition and exercise statuses, we found no significant association between MS and osteoporosis in either gender.PurposeThe term metabolic syndrome (MS) encompasses different abnormalities with independent effects on bone metabolism, which has led to inconsistencies in the association between MS and osteoporosis. This study evaluated this association among middle-aged and elderly Taiwanese participants by adjusting relevant covariates.MethodsWe enrolled 2007 participants (1045 men and 962 women) older than 50 years, who underwent a health examination at a preventive examination agency in urban Taiwan. We studied age, gender, diabetes mellitus and hypertension histories, smoking and exercise statuses, metabolic and nutrition indices, and liver and renal function profiles. We conducted multiple logistic regression analyses to examine the association between MS and osteoporosis by categorizing participants in terms of gender and body mass index (BMI).ResultsOverall, men with osteoporosis were less likely to have MS, and displayed fewer MS components than men without osteoporosis; but we found no significant associations between MS, or its components, and osteoporosis in women. After forming two groups according to BMI and adjusting for covariates, we found no association between MS and osteoporosis in any group. Multiple logistic regression analysis revealed that regular exercise had a negative association with osteoporosis in the low BMI group for men (OR, 0.365; p = 0.008).ConclusionsAfter BMI stratification and adjustments for age, nutrition status, liver and renal functions, and exercise status, we found no significant association between MS and osteoporosis in either gender. Regular exercise may prevent osteoporosis, particularly in men with a lean body mass.

show abstract

Section: Introductionmentioning

confidence: 99%

Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants

2018

View full text Add to dashboard Cite

show abstract

“…In the primary search, 60 full text articles were related to our topic. After considering inclusion and exclusion criteria, 20 articles were included to qualitative analysis [8,15,[18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35]. In each selected study, the prevalence of MetS was reported according to different criteria; 17 reports based on NCEP ATPIII [8, 15, 18-29, 31, 33-35], 3 reports [22,27,32] based on IDF (2 reports were separately given prevalence data based on NCEP ATPIII and IDF criteria), 2 reports based on World Health Organization (WHO) and the other based on American Heart Association (AHA) [26,30].…”

Section: Resultsmentioning

confidence: 99%

“…Since, the related studies were found just from two countries of the Middle East region; Iran and Turkey, sub-group analysis was performed based on these countries. Among 17 studies, 11 reports were from Iran [8,15,18,20,21,23,24,27,28,33,34], and others were from Turkey [19,22,25,29,31,35].…”

Section: Resultsmentioning

confidence: 99%

Menopause and metabolic syndrome in the Middle East countries; a systematic review and meta-analysis study

Tabatabaei‐Malazy

Djalalinia

Asayesh

et al. 2018

J Diabetes Metab Disord

View full text Add to dashboard Cite

Introduction Metabolic syndrome (MetS) prevalence that is associated with increasing risk of diabetes and cardiovascular diseases (CVD) has accelerated with age. Since, menopause is known as a partial cause of CVD accelartion with againg among women, determining the prevalence of MetS is important in this condition. We aimed to assess critically the prevalence rate of MetS among menopaused women in the Middle East Countries in this systematic review meta-analysis study. Methods & Materials International webdata bases including Scopus, ISI web of Science and PubMed were systematically searched using Medical Subject Headings terms from January 2000 to February 2017. We included all cross-sectional conducted in the Middle East that reported prevalence of MetS in menopause status regardless of MetS definition. Quality assessment was considered for each included study. The pooled prevalence of MetS based on the Adult Treatment Panel III (ATP III) was estimated using random effect method due to between-study heterogeneity by STATA software, version 11.0 (StataCorp, USA). Results Within 60 studies, 21 and 17 studies were included in qualitative synthesis and meta-analysis respectively. The prevalence of MetS among menopaused women was estimated 54.87% (95% CI: 53.76-55.97) in the Middle East countries. In subgroup analysis based on country the prevalence rate of MetS in Iran and Turkey was estimated 58.78% (95% CI: 57.54-60.02), and 39.02% (95% CI: 36.57-41.47), respectively. Conclusions MetS was highly prevalent as an alarming sign among menopaused women in the Middle East countries. Thus, it is an emergency requirement to promote healthy lifestyle. Also, early detection and treatment of women who reach menopause and are at great risk of developing MetS is necessary for prevention of diabetes and CVD in the region.

show abstract

“…First group's bone density was in anterior wall 160. 1 Also we've marked that the highest bone density was in posterior wall. The highest bone density in control group was in anterior wall.…”

Section: выводыmentioning

confidence: 92%

“…Период менопаузы ассоциируется со значительными изменениями в организме женщин. Важнейшие из них связаны с гормональным дисбалансом: происходит повышение уровней гонадотропных гормонов гипофиза и снижение количества эстрогенов, что влияет на физиологическую работу органов-мишеней, в частности, костной ткани [1]. Остеопороз приводит к перестройкам в костях, снижению их плотности, микроархитектурным изменениям в составе кости и, как следствие -к нарушению функции.…”

unclassified

Untitled

Gargin¹,

Alekseeva²,

Lupyr³

et al. 2019

PEP

View full text Add to dashboard Cite

Работа выполнена в рамках плановой комплексной научно-исследовательской темы Харьковского национального медицинского университета «Морфологические особенности органов и систем тела человека на разных этапах онтогенеза», (государственный регистрационный № 0144U004149). Учреждением, финансирующим исследование, является МЗ Украины. Авторы гарантируют ответственность за объективность представленной информации. Авторы гарантируют отсутствие конфликта интересов и собственной финансовой заинтересованности. Рукопись поступила в редакцию 14.12.2018.

show abstract

Relationship between metabolic syndrome and its components with bone densitometry in postmenopausal women

Cited by 19 publications

References 17 publications

Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants

Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants

Menopause and metabolic syndrome in the Middle East countries; a systematic review and meta-analysis study

Untitled

Contact Info

Product

Resources

About